IDEXX Laboratories' stock plummeted 6.03% intraday on Monday, as the animal diagnostics company reported fourth-quarter earnings that narrowly missed analyst expectations.

The company posted comparable earnings per share of $2.92 for the quarter, slightly below the consensus estimate of $2.93 from analysts polled by FactSet. This earnings miss occurred despite revenue of $1.09 billion beating estimates of $1.07 billion.

Investors reacted negatively to the earnings shortfall, driving the stock price down significantly at the market open. The slight miss on the bottom line overshadowed the revenue beat and contributed to the sharp decline in share price during the trading session.